96964-45-3

Upstream product

• 78573-85-0 1-bromo-7-phenyl-heptane 
• 106745-25-9 N-<(2-Methylphenyl)methylene>-1,1-dimethylethanamine 
• 54636-29-2 1-chloro-7-phenylheptane 
• 6921-34-2 benzylmagnesium chloride 
• 928-90-5 5-hexyl-1-ol 
• 10472-97-6 8-phenyloctan-1-ol 
• 96964-47-5 1-(octa-1,7-diynyl)benzene 
• 6630-33-7 ortho-bromobenzaldehyde 
• 110-18-9 N,N,N,N,-tetramethylethylenediamine 
• 155570-08-4 tert-butyl-(2-methylbenzylidene)amine 
• 4440-01-1 lithium phenylacetylide 
• 96964-42-0 2-[2-(8-phenyloctyl)phenyl]-4,4-dimethyloxazoline 
• 536-74-3 phenylacetylene 
• 76911-01-8 5-hexynyl p-toluenesulfonate 

Downstream Products

• 121441-81-4 (R^*,R^*)-methyl β-hydroxy-α-methoxy-2-(8-phenyloctyl)benzenepropanoate 
• 121441-81-4 (R^*,S^*)-methyl β-hydroxy-α-methoxy-2-(8-phenyloctyl)benzenepropanoate 
• 120379-24-0 tert-butyl 3-hydroxy-3-[2-(8-phenyloctyl)phenyl]propionate 
• 108082-09-3 ((+/-)-trans)-Methyl 3-<2-(8-phenyloctyl)phenyl>oxiranecarboxylate 
• 96964-40-8 SKF 102922 
• 463308-92-1 trans-N,N-diethyl-3-[2-(8-phenyloctyl)phenyl]-2,3-epoxypropionamide 
• 880175-79-1 1-({(2R,3S)-3-[2-(8-phenyloctyl)phenyl]oxiranyl}carbonyl)-2,5-dihydropyrrole 
• 121441-81-4 Methyl 2-methoxy-3-hydroxy-3-[2-(8-phenyloctyl)phenyl ]propanoate 
• 120379-10-4 Methyl 3-[2-(8-phenyloctyl)phenyl]-2,3-epoxypropionate 
• 134915-17-6 (E)-1-(4-fluorophenyl)-3-[2-(8-phenyloctyl)phenyl]-2-propen-1-one 
• 145950-32-9 (2R,3S)-(+) methyl 2,3-dihydroxy-3-<2-(8-phenyloctyl)phenyl>propionate 
• 108116-15-0 (2R,3S)-3-(2-Carboxy-ethylsulfanyl)-2-hydroxy-3-[2-(8-phenyl-octyl)-phenyl]-propionic acid 
• 107023-40-5 2(S)-hydroxy-3(R)-(2-carboxyethylthio)-3-[2(8-phenyloctyl)phenyl]-propanoic acid 
• 120427-74-9 methyl-α-hydroxy-β-[(2-(methoxycarbonyl)ethyl)thio]-2-(8-phenyloctyl)benzenepropanoate 

Relevant academic research and scientific papers

Highly enantioselective synthesis of glycidic amides using camphor-derived sulfonium salts. Mechanism and applications in synthesis

The reactions of a range of amide-stabilized sulfur ylides derived from readily available camphor-derived sulfonium salts for the synthesis of glycidic amides have been studied. Primary, secondary, and tertiary amides were tested, and it was found that th

Processes and intermediates for the preparation of 2-substituted benzaldehydes

Processes for preparing 2-substituted benzaldehydes of general formula (I), wherein: R1 is CH2 CH2 --(L1)p --(CH2)q --(L2)r --CH2 --(T)2/su

LEUKOTRIENE ANTAGONISTS

This invention relates to alkanoic acid compounds having phenyl and heteroarylthio substituents which are useful as leukotriene antagonists, processes for the preparation thereof, and pharmaceutical compositions containing such compounds.This invention also relates to methods of treating diseases in which leukotrienes are a factor by administration of an effective amount of the above compounds or compositions.

Leukotriene antagonists

Leukotriene antagonist thiadiazoles have been prepared.

LEUKOTRIENE ANTAGONISTS CONTAINING TETRAZOLYL GROUPS

This invention relates to alkanoic acid compounds having phenyl and heteroarylthio substituents which are useful as leukotriene antagonists and pharmaceutical compositions containing such compounds. This invention also relates to methods of treating diseases in which leukotrienes are a factor by administration of an effective amount of the above compounds or compositions.

ESTER PRODRUGS

This invention relates to ester prodrugs for alkanoic acid compounds useful as leukotriene antagonists, and pharmaceutical compositions containing such ester prodrug compounds. This invention also relates to methods of treating diseases in which leukotrienes are a factor by administration of an effective amount of the above compounds or compositions.

Leukotriene antagonists

This invention relates to alkanoic acid compounds having phenyl and heteroarylthio substituents which are useful as leukotriene antagonists, pharmaceutical compositions containing such compounds, and methods of treating diseases in which leukotrienes are a factor by administration of an effective amount of the above compounds or compositions.

THIOPHENYL ALKANOIC ACIDS USEFUL AS LEUKOTRIENE ANTAGONISTS

This invention relates to alkanoic acid compounds having phenyl and thio substituents which are useful as leukotriene antagonists and pharmaceutical compositions containing such compounds. This invention also relates to treating diseases in which leukotrienes are a factor by administration of an effective amount of the above compounds or compositions.